Journal of Parathyroid Disease

News and Views

pp. 32 - 32

Cost analysis for somatic and germline SyBr Green PCR method screening for parathyroid gland; a cost analysis from Thailand

Sora Yasri, Viroj Wiwanitkit

PDF XML Abstract doi: 10.15171/jpd.2018.11

Hypothesis

pp. 33 - 33

Anti-receptor activator nuclear factor κ-B ligand (anti-RANKL) as an antiresorptive agent for renal failure osteoporotic patient

Mansoor Karimifar, Mozhgan Karimifar

PDF XML Abstract doi: 10.15171/jpd.2018.12

Epidemiology and Prevention

pp. 34 - 35

The underlying pathology of primary hyperparathyroidism; a summary on 87 published cases in Thailand

Sora Yasri, Viroj Wiwanitkit

PDF XML Abstract doi: 10.15171/jpd.2018.13

Review

pp. 36 - 38

The need for a reliable bone biomarker to better assess chronic kidney disease mineral and bone disorder

Ramin Tolouian, Ajay Gupta

PDF XML Abstract doi: 10.15171/jpd.2018.14

Original

pp. 39 - 41

Calcium and vitamin D supplements administration in patients with nephrolithiasis; an observational prospective study

Marwan Ghazi Akel, Iqbal Mohamad Fahs

PDF XML Abstract doi: 10.15171/jpd.2018.15

Epidemiology and Prevention

pp. 42 - 43

Abnormal parathyroid in some important tropical parasitic infections: a new trend

Sora Yasri, Viroj Wiwanitkit

PDF XML Abstract doi: 10.15171/jpd.2018.16

Original

pp. 44 - 49

Association of serum phosphorus, calcium and parathyroid hormone with cardiovascular calcification in regular hemodialysis patients

Alireza Nematollahi, Mohammad-Reza Tamadon, Parisa Irannejad, Milad Fouladgar, Mohammad Bahadoram, Saeed Mardani

PDF XML Abstract doi: 10.15171/jpd.2018.17

Original

pp. 50 - 56

Bone mineral density and bone metabolism biochemical markers in patients with chronic kidney disease at the hemodialysis treatment

Mohammad Reza Tamadon, Jamileh Moghimi, Vahid Semnani

PDF XML Abstract doi: 10.15171/jpd.2018.18

Original

pp. 57 - 63

Relationship of bone density with serum parathyroid hormone in hemodialysis patients; a single center study

Bita Omidvar, Ali Ghorbani, Mohammad Reza Tamadon, Zahra Sadeghian Broujeni

PDF XML Abstract doi: 10.15171/jpd.2018.19

Brief Communication

pp. 64 - 67

Secondary hyperparathyroidism among end-stage renal disease patients in Beharlou hospital, Tehran province, Iran

Seyed Majid Mousavi Movahed, Seyed Seifollah Beladi Mousavi, Mohammad Faramarzi

PDF XML Abstract doi: 10.15171/jpd.2018.20

Case Report

pp. 68 - 71

Superior vena cava syndrome complicating calcific uremic arteriolopathy in an ESRD male patient on maintenance hemodialysis following failed kidney transplantation

Macaulay Amechi Chukwukadibia Onuigbo, Nneoma Agbasi, Abdul Khan, Vinay Nijhawan, Zhibin Jiang

PDF XML Abstract doi: 10.15171/jpd.2018.21

Commentary

pp. 72 - 73

Magnesium and parathyroid hormone among end-stage renal disease patients

Seyed Seifollah Beladi Mousavi, Fatemeh Hayati, Shokouh Shayanpour, Shahla Ahmadi Halili

PDF XML Abstract doi: 10.15171/jpd.2018.22

Commentary

pp. 74 - 75

Administration of calcium and vitamin D supplementation in kidney stone formers

Tayebeh Soleymanian

PDF XML Abstract doi: 10.15171/jpd.2018.23

Commentary

pp. 76 - 77

Hyperparathyroidism after renal transplantation

Farahnaz Dadras, Farhad Khoshjou

PDF XML Abstract doi: 10.15171/jpd.2018.24

Commentary

pp. 78 - 79

The prevalence of vitamin D deficiency is alarming high

Seyed Majid Mousavi Movahhed, Seyed Seifollah Beladi Mousavi2, Shokouh Shayanpour, Shahla Ahmadi Halili, Leila Sabetnia

PDF XML Abstract doi: 10.15171/jpd.2018.25

Original

pp. 80 - 86

Cinacalcet therapy for achievement of the NKF/K-DOQITM clinical practice guidelines for bone and mineral metabolism in individuals under regular hemodialysis

Taoufiq Aatif, Najet El Esper, Philippe Moriniere, Gabriel Choukroun, Albert Fournier

PDF XML Abstract doi: 10.15171/jpd.2018.26

Original

pp. 87 - 90

Cholecalciferol versus calcitriol to manage secondary hyperparathyroidism in hemodialysis patients

Hamid Reza Omrani, Ali Daraizade

PDF XML Abstract doi: 10.15171/jpd.2018.27